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Distinct glial cell types of the vertebrate peripheral nervous system (PNS) are derived from the neural crest. Here we show
that the expression of the Ets domain transcription factor Erm distinguishes satellite glia from Schwann cells beginning
early in rat PNS development. In developing dorsal root ganglia (DRG), Erm is present both in presumptive satellite glia and
in neurons. In contrast, Erm is not detectable at any developmental stage in Schwann cells in peripheral nerves. In addition,
Erm is downregulated in DRG-derived glia adopting Schwann cell traits in culture. Thus, Erm is the first described
transcription factor expressed in satellite glia but not in Schwann cells. In culture, the Neuregulin1 (NRG1) isoform GGF2
maintains Erm expression in presumptive satellite cells and reinduces Erm expression in DRG-derived glia but not in
Schwann cells from sciatic nerve. These data demonstrate that there are intrinsic differences between these glial subtypes
in their response to NRG1 signaling. In neural crest cultures, Erm-positive progenitor cells give rise to two distinct glial
subtypes: Erm-positive, Oct-6-negative satellite glia in response to GGF2, and Erm-negative, Oct-6-positive Schwann cells
in the presence of serum and the adenylate cyclase activator forskolin. Thus, Erm-positive neural crest-derived progenitor
cells and presumptive satellite glia are able to acquire Schwann cell features. Given the in vivo expression of Erm in
peripheral ganglia, we suggest that ganglionic Erm-positive cells may be precursors of Schwann cells. © 2000 Academic Press
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Glial cells of the vertebrate PNS consist of myelinating
and nonmyelinating Schwann cells of peripheral nerves, the
satellite glia of sensory, sympathetic and parasympathetic
ganglia, and the enteric glia. All of these cell types are
derived from the neural crest, but it is still unclear how
their phenotypic characteristics arise (Le Douarin et al.,
1991; Le Douarin, 1982). In avian embryos, the Schwann
cell myelin protein (SMP) is expressed only by Schwann
1 Present address: Department of Immunology and Oncology,
Centro Nacional de Biotecnologia/CSIC, UAM Campus Canto-
blanco, Madrid E-2804, Spain.
2 To whom correspondence should be addressed. Fax: 41 1 633 11
g0. E-mail: sommer@cell.biol.ethz.ch.
44ells but not by satellite cells or enteric glia (Dulac et al.,
988). Satellite and enteric glia have the potential to express
MP when withdrawn from their ganglionic or enteric
nvironment, suggesting that inhibitory cues suppress a
lial default pathway characterized by SMP expression
Cameron-Curry et al., 1993; Dulac and Le Douarin, 1991).
imilarly, in mouse embryos, Schwann cells but not satel-
ite glia express the transcription factor Krox20 (Topilko et
l., 1994). The microenvironment of sensory ganglia ap-
ears to negatively regulate Krox20 expression since cul-
ured satellite cells are able to upregulate Krox20 (Murphy
t al., 1996). The conversion of satellite cells, as defined by
he absence of Schwann cell markers, to SMP-positive or
rox20-positive Schwann cells indicates that peripheral
lia are derived from a common precursor (Cameron-Curry
0012-1606/00 $35.00
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45Ets Factor Erm in Satellite Glia but Not Schwann Cellset al., 1993; Le Douarin et al., 1991; Murphy et al., 1996).
This hypothesis was supported by clonal analysis of neural
crest cultures, in which bipotent precursors giving rise to
both SMP-positive and SMP-negative glial cells were found
(Dupin et al., 1990).
The nature of the signals that regulate subtype-specific
glial markers is poorly understood, but both inhibitory and
inducing factors may be involved. The neurotrophins BDNF
and NGF exert a positive effect on SMP expression in glial
cells derived from quail dorsal root ganglia (DRG), while
NT3 prevents SMP expression (Pruginin-Bluger et al.,
1997). A crucial role at several stages of gliogenesis has been
attributed to Neuregulin1 (NRG1). NRG1, a member of the
epidermal growth factor superfamily, influences growth
and differentiation of various cell types including neurons
and glia (Burden and Yarden, 1997; Gassmann and Lemke,
1997). In peripheral gliogenesis, the NRG1 isoform GGF2
has been shown to instructively bias multipotent neural
crest stem cells and neural crest derivatives to choose a glial
fate (Hagedorn et al., 1999; Morrison et al., 1999; Shah et
al., 1994), although it was not determined which glial
subtypes are produced from these cultures due to the lack of
appropriate markers. In the Schwann cell lineage, NRG1
promotes the survival and maturation of Schwann cell
precursors (Dong et al., 1995) and exerts a mitogenic and
antiapoptotic effect on postnatal Schwann cells (Goodearl
et al., 1993; Grinspan et al., 1996; Levi et al., 1995;
Marchionni et al., 1993; Syroid et al., 1996; Trachtenberg
and Thompson, 1996). Mice with targeted mutations of
NRG1, or of ErbB receptors transmitting NRG1 signaling,
exhibit severely reduced numbers of both Schwann cell
precursors in peripheral nerves and neuronal and glial cells
in cranial and sympathetic ganglia (Britsch et al., 1998;
Erickson et al., 1997; Gassmann et al., 1995; Kramer et al.,
1996; Lee et al., 1995; Meyer and Birchmeier, 1995; Meyer
et al., 1997; Morris et al., 1999; Riethmacher et al., 1997).
However, the generation of presumptive satellite cells in
DRG is apparently not affected in these mutants (Morris et
al., 1999; Riethmacher et al., 1997; Woldeyesus et al.,
1999). The analysis of ErbB2-null embryos, in which glial
cells appear to accumulate in the nerve roots of the DRG
and Schwann cells are not found in peripheral nerves, led to
the proposal that in wild-type animals, satellite glia emi-
grate from the ganglia into peripheral nerves where they
acquire a Schwann cell fate (Morris et al., 1999). According
to this model, NRG1 signaling might be required to pro-
mote a glial differentiation state compatible with migration
or might stimulate migration directly.
An early marker expressed by developing satellite glia but
not by Schwann cells would greatly facilitate investigations
aimed at understanding the relationship between these
neural crest-derived glial subtypes. Here we show that the
Ets domain transcription factor Erm (Monte´ et al., 1994) is
expressed by sensory neurons and satellite glia early in
development but is not expressed at any time by Schwann
cells. The NRG1 isoform GGF2 instructs Erm-positive
progenitors in neural crest cultures to give rise to Erm- m
Copyright © 2000 by Academic Press. All rightpositive glia and regulates Erm expression in cultured
satellite cells. Moreover, Erm-positive cells derived either
from cultures of neural crest or from DRG are able to
generate Schwann cells. Finally, while satellite glia are able
to undergo a transition to Schwann cells, GGF2 does not
convert Schwann cells to Erm-positive satellite glia at any
stage investigated.
MATERIALS AND METHODS
Nonradioactive in Situ Hybridization
Using Chromogens
Nonradioactive in situ hybridization with digoxigenin-labeled
iboprobes was performed on frozen sections of paraformaldehyde-
xed mouse embryos (Birren et al., 1993; Sommer et al., 1996) with
he modifications described in Paratore et al. (1999). NBT/BCIP
ere used as chromogens to visualize the hybridization signals.
ntisense riboprobes were as follows: partial mouse Erm cDNA
as a gift from Amgen; and murine Ets-1 was cloned by RT-PCR
rom 4-week mouse brain cDNA using the gene-specific primers
ts-5 (59primer, cgggatccATGAAGGCGGCCGTCGATC) contain-
ng a BamHI site (small letters) and Ets-6 (39primer, acggtaccGGT-
TATCCCAGCAGGCT) containing a KpnI site. The cDNA was
ubjected to PCR (40 cycles: 1 min 94°C, 1 min 55°C, 1 min 72°C).
he PCR products were digested with the appropriate restriction
nzymes and cloned into the Bluescript (pBS) SK- vector (Stratagene
loning Systems).
Fluorescence in Situ Hybridization Combined
with Immunohistochemistry
Tyramide signal amplification (TSA) was applied to detect Dig-
labeled Erm riboprobe by fluorescence in situ hybridization. A
detailed protocol has been published elsewhere (Paratore et al.,
1999). Briefly, subsequent to the riboprobe hybridization, sections
were treated for 15 min with freshly prepared 1% H2O2 in metha-
ol in order to block endogenous peroxidase activity and washed
hree times with TNT (0.1 M Tris–HCl, pH 7.5, 0.15 M NaCl,
.05% Tween 20) for 5 min each. A blocking step with TNB (0.1 M
ris–HCl, pH 7.5, 0.15 M NaCl, 0.5% blocking reagent; blocking
eagent supplied by NEN Life Science Products) for 30 min at RT
as followed by a 30-min incubation with HRP-coupled sheep
nti-Dig antibody (Roche Diagnostics) diluted at 1:100 in TNB.
ubsequently, the sections were washed in TNT and mRNA
xpression was detected with Cy3-labeled tyramide prepared ac-
ording to the manufacturer’s instructions (NEN Life Science
roducts). Incubation with Cy3-labeled tyramide was for 12 min.
To combine detection of mRNA with the analysis of protein
xpression, immunofluorescence was carried out subsequent to the
ast washing step of the TSA in situ hybridization protocol. The
ections were blocked for 30 min in 10% normal goat serum, 0.3%
riton-X 100, 0.1% BSA in PBS and then incubated for 2 h with a
ouse monoclonal anti-neurofilament (NF160) antibody (1:100
ilution; Sigma) or a rabbit polyclonal anti-ErbB3 antibody (1:100
ilution; Santa Cruz Biotechnology), respectively. Detection was
y FITC-conjugated secondary antibodies (anti-mouse antibody,
ector Laboratories; anti-rabbit antibody, Jackson ImmunoRe-
earch Laboratories). After being washed in PBS, the sections were
ounted in AF1 (Citifluor). Samples were analyzed by confocal
icroscopy.
s of reproduction in any form reserved.
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46 Hagedorn et al.Cell Culture
Time-mated OFA rats were obtained from Biological Research
Laboratories (Fullinsdorf, Switzerland). DRG were dissected from
E14 or E16 embryos and dissociated by incubation in 0.25% trypsin
(Gibco BRL), 0.3 mg/ml collagenase type I (Worthington Biochemi-
cal) in Ca21/Mg21-free Hank’s; balanced salt solution (Amimed) for
5 min, followed by addition of 1/10 vol of FBS. The cells were
entrifuged for 3 min at 1800 rpm, washed once in standard culture
edium (Stemple and Anderson, 1992), and plated at approxi-
ately 300 cells per 35-mm culture dish (Corning) coated with 0.5
g/ml poly-D-lysine (Roche Diagnostics) and 0.25 mg/ml fibronec-
in (FN) (Roche Diagnostics). DRG cultures were maintained in
tandard culture medium. In some experiments, 1 nM rhGGF2, a
oluble NRG1 isoform (a gift from M. Marchionni, Cambridge
euroScience), was added 3 h after plating the cells; alternatively,
ells were treated with standard culture medium supplemented
ith 10% FBS and 5 mM forskolin (Sommer et al., 1995; Stemple
nd Anderson, 1992). Neural crest cell cultures were performed as
eported in Hagedorn et al. (1999). Sciatic nerves from E14, E16, or
18 embryos were dissected and dissociated as in Morrison et al.
1999). Cells isolated from sciatic nerves were then centrifuged,
ashed, and plated as described above for DRG cultures.
Immunocytochemistry
Living cells were labeled for the cell surface antigen p75 for 30
min in standard culture medium using a monoclonal mouse
antibody (Ig192) (Roche Diagnostics) visualized by Cy3-conjugated
goat anti-mouse IgG (Jackson ImmunoResearch Laboratories). To
label intracellular antigens, cells were fixed in PBS containing 3.7%
formaldehyde for 10 min at room temperature (RT) and permeabil-
ized for 15 min at RT using 10% goat serum, 0.3% Triton X-100,
0.1% BSA in PBS. Rabbit polyclonal anti-Erm antibodies
(Janknecht et al., 1996) were affinity purified using Reacti-Gel
HW-65 according to the manufacturer’s instructions (Pierce). Erm
labeling (antibody dilution 1:200) was performed for 2 h at RT,
followed by incubation with biotin-SP-conjugated donkey anti-
rabbit IgG antibody (Jackson ImmunoResearch Laboratories).
Staining was visualized by the ABComplex kit (DAKO) with
horseradish peroxidase development using diaminobenzidine as
substrate. Rabbit anti-Oct-6/SCIP antibody (Zwart et al., 1996) (a
gift from D. Meijer, Erasmus University, Rotterdam, The Nether-
lands) was used at a 1:200 dilution in 10% goat serum, 1% Triton
X-100, 0.1% BSA in PBS for 45 min at RT and visualized with
Cy3-conjugated goat anti-rabbit IgG secondary antibody (Jackson
ImmunoResearch Laboratories). To reveal glial fibrillary acidic
protein (GFAP) expression, a mixture of monoclonal anti-GFAP
antibodies Ab-1 and Ab-2 (IgG) (NeoMarkers; each used at a 1:100
dilution) was applied for 1 h at RT, followed by staining with either
Cy3-conjugated (Jackson ImmunoResearch Laboratories) or FITC-
conjugated (Vector Laboratories) goat anti-mouse IgG. Staining with
monoclonal anti-NF160 antibody NN18 (IgG) (1/100 dilution; Sigma)
was performed for 1 h at RT and visualized by Cy3 fluorescence.
RESULTS
Spatiotemporal Expression of Erm in Neural Crest
Derivatives
In order to address whether Erm might be involved in the
development of the PNS, we investigated the expression
Copyright © 2000 by Academic Press. All rightattern of Erm in a series of in situ hybridization experi-
ents focusing on the neural crest and its derivatives at
arious developmental stages. At early stages (E8.5), Erm is
ot expressed in migrating neural crest cells (Fig.1, open
rrow in B) which are positive for the Ets domain transcrip-
ion factor Ets-1 (arrow in Fig. 1A) (Fafeur et al., 1997;
aroulakou et al., 1994). As soon as neural crest cells
ggregate in the presumptive DRG, Ets-1 expression is
ownregulated (data not shown). In E11 embryos, a small
opulation of cells at the ventrolateral margin of the form-
ng DRG starts to display Erm expression (arrow in Fig. 1C);
y E12, Erm mRNA is abundant (Fig. 1D). Erm expression
ersists in the DRG up to postnatal day (P) 4, the latest time
oint examined (Fig. 1E). However, Erm mRNA was not
etectable in presumptive Schwann cells found along pe-
ipheral nerves at any developmental stage analyzed (E9 to
4) (open arrow in Figs. 1D and 1E). Apart from its expres-
ion in DRG, Erm mRNA was also present in other periph-
ral ganglia, such as in developing sympathetic and cranial
ensory ganglia (data not shown).
Erm Is Expressed in Neurons and Satellite Glia
of Developing DRG but Not in Presumptive
Schwann Cells
The in situ hybridization analysis did not settle the
question whether Erm is expressed in neurons and/or pre-
sumptive glia within the developing DRG. Unfortunately,
the available antibodies to Erm (see below) were not sensi-
tive enough to be suitable for immunohistochemistry.
Therefore, we applied a fluorescence hybridization method
that we have recently established, to address the cellular
expression of Erm in the developing PNS in situ (Paratore
et al., 1999). The procedure is based on TSA using
fluorophore-labeled tyramide. When combined with confo-
cal microscopy, this allows the simultaneous detection of
distinct mRNA species or of mRNAs together with proteins
on the cellular level. In the PNS, the NRG1 receptor ErbB3
is expressed in migrating neural crest and in developing
glial cells (Meyer and Birchmeier, 1995). In agreement with
previous studies (Meyer et al., 1997; Morris et al., 1999),
prominent ErbB3-positive cells were found at the ventrolat-
eral margins of the DRG at E12 (Fig. 2A). Hybridization of
E12 mouse embryo sections with an antisense Erm ribo-
probe followed by ErbB3 immunofluorescence demon-
strated that the ErbB3-positive presumptive glial cells of
DRG coexpressed Erm mRNA (Figs. 2A–2C). A sense Erm
probe did not produce fluorescent signals (data not shown).
In contrast, ErbB3-positive glial precursor cells along pe-
ripheral nerves did not express Erm mRNA (Figs. 2D–2F),
corroborating the conventional in situ hybridization experi-
ments (Fig. 1). Thus, Erm is expressed in presumptive
satellite glia but not in developing Schwann cells. In the
DRG, however, Erm transcripts are not restricted to the
glial lineage but are also found in neuronal cells positive for
neurofilament (NF160) protein (Figs. 2G–2I). Fluorescence
s of reproduction in any form reserved.
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47Ets Factor Erm in Satellite Glia but Not Schwann Cellsin situ hybridization on motor neurons did not reveal Erm
expression (data not shown).
To investigate the cellular expression of Erm protein in
DRG, an antibody directed to a peptide corresponding to the
N-terminus of Erm (Janknecht et al., 1996) was affinity
purified. In transfection experiments, the antibody did not
crossreact with Er81 and Pea3, the most closely related Ets
domain transcription factors (data not shown) (Brown and
McKnight, 1992; de Launoit et al., 1997; Xin et al., 1992).
FIG. 1. Erm expression in developing dorsal root ganglia. (A, B) Er
ections through an E8.5 mouse embryo were hybridized with Ets-1
art of the neural tube (nt) are positive for Ets-1 (arrow in A) but no
4 (E) mouse trunk regions hybridized with Erm riboprobe. A few ce
n C). At E12, transcripts encoding Erm are strongly expressed in th
n E). Note that Erm is not expressed in presumptive Schwann cel
C, D) 100 mm; (E) 1 mm.DRG dissected from rat E16 embryos were dissociated and T
Copyright © 2000 by Academic Press. All rightxed 4 h after plating. In such cultures, Erm was detectable
y a biotin/avidin-based immunoreaction both in virtually
ll NF160-positive neurons and in satellite glia identified by
he expression of GFAP (Figs. 3A and 3C), consistent with
he fluorescence in situ hybridization results. Strikingly,
irtually all GFAP-positive cells expressed Erm suggesting
hat this Ets domain transcription factor is a marker for the
ast majority of developing glia in E16 DRG. In contrast,
he POU transcription factor Oct-6 (also called SCIP or
not detectable in migrating neural crest cells. Adjacent transverse
Erm riboprobes. Migrating neural crest cells arising from the dorsal
Erm (open arrow in B). Transverse sections of E11 (C), E12 (D), and
ithin the dorsal root ganglia (drg) start to express Erm at E11 (arrow
rsal root ganglia (arrow in D) and persist to postnatal stages (arrow
ng peripheral nerves (open arrows in D and E). Bars: (A, B) 50 mm;m is
and
t for
lls w
e do
ls alost-1; He et al., 1989; Meijer et al., 1990; Monuki et al.,
s of reproduction in any form reserved.
48 Hagedorn et al.FIG. 2. Cellular localization of Erm mRNA in ErbB3-positive presumptive satellite glia and in NF160-positive sensory neurons. Sections
through mouse E12 DRG (A–C, G–I) and peripheral nerve (D–F) were hybridized with Erm riboprobe (A, D, G). Fluorescence in situ
hybridization using Cy3-coupled tyramide was followed by immunohistochemistry using anti-ErbB3 antibody (B, E) or anti-neurofilament
(NF)160 antibody (H). Immunoreactions were visualized by FITC-conjugated secondary antibodies and the stainings were analyzed by
confocal microscopy. Single confocal planes are shown. (C), (F) and (I) represent the confocal overlays of (A, B), (D, E), and (G, H),
respectively. Yellow color indicates double-positive cells (arrows in C) revealing individual presumptive satellite glia coexpressing Erm and
ErbB3. Likewise, NF-positive neurons in the DRG are double-positive for Erm mRNA expression (arrow in I). However, Erm signals were
not detectable in ErbB3-positive presumptive Schwann cells in peripheral nerves (D–F). Note that at early stages in development, neuronal
and glial cell types can barely be distinguished on ganglionic sections solely based on their morphology (Hall and Landis, 1992). Bars: (A–C,
G–I) 10 mm; (D–F) 20 mm.
Copyright © 2000 by Academic Press. All rights of reproduction in any form reserved.
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49Ets Factor Erm in Satellite Glia but Not Schwann Cells1989), which is expressed in promyelinating Schwann cells
found along peripheral nerves (Arroyo et al., 1998; Blan-
chard et al., 1996; Scherer et al., 1994; Zorick et al., 1996),
as barely detectable in satellite glia (Figs. 3B and 3D).
Differential Regulation of Erm and Oct-6 in
Peripheral Glia: Role of the NRG1 Isoform
GGF2 in Maintenance of Erm Expression
In cultures of DRG, satellite cells can acquire character-
istics of Schwann cells. Krox20 and SMP are expressed by
developing Schwann cells but not by satellite cells (Dulac et
al., 1988; Topilko et al., 1994). Both Krox20 and SMP are
upregulated in glia of serum-treated DRG cultures, reveal-
ing that at least in vitro, a transition from satellite cells to
Schwann cells is possible (Cameron-Curry et al., 1993;
Murphy et al., 1996). To investigate the regulation of Erm
protein expression in glia acquiring Schwann cell features,
cultures of dissociated DRG (E16) were incubated for 6 days
in the presence of serum and forskolin which is known to
result in upregulation of myelin genes (reviewed by Mirsky
and Jessen, 1996; Zorick and Lemke, 1996). In such cul-
tures, the GFAP-positive glial cells (Figs. 4D and 4K) under-
went massive proliferation, became positive for the
Schwann cell marker Oct-6 (Fig. 4G), and lost Erm expres-
sion (Fig. 4A). These results strongly suggest that serum/
forskolin promoted the transition of Erm1/Oct-62 satellite
glia (Fig. 3) into Erm2/Oct-61 Schwann cells (Fig. 4).
While serum/forskolin was required to induce Oct-6
xpression in DRG-derived glia, downregulation of Erm
xpression was serum/forskolin independent. In dissociated
RG, most glial cells lost Erm expression even when
ultured without serum/forskolin (Fig. 4B). However, the
eurons, identified by their morphology and by NF160
xpression (inset in Fig. 4E), continued to express Erm (inset
n Fig. 4B). Thus, different regulatory mechanisms govern
rm expression in neurons and glia. Since Erm expression is
etectable in nonneuronal components of DRG both in situ
nd in freshly isolated cultures, we considered that glial
xpression is lost upon cellular dissociation due to dilution
f a positively acting signal. NRG1 is a good candidate for
uch an activity given its coordinate expression with Erm in
RG and in other developing tissues (data not shown) and
ince Ets domain transcription factors have been suggested
o be potential targets of NRG signaling (Galang et al.,
996; Janknecht, 1996; Janknecht et al., 1996; Khurana et
l., 1999; Marais et al., 1993; O’Hagan and Hassell, 1998;
’Hagan et al., 1996; Sapru et al., 1998; Schaeffer et al.,
998; Yang et al., 1996). To test this hypothesis, we exam-
ned the effect of the NRG1 isoform GGF2 on cultures of
issociated DRG. In contrast to serum/forskolin, GGF2
aintained Erm protein expression in virtually all GFAP-
ositive glial cells (Figs. 4C and 4F). Based on in vivo
xpression data, the presence of Erm indicates that these
RG-derived, GGF2-treated cells are satellite glia. In agree- S
Copyright © 2000 by Academic Press. All rightent with this, GGF2 did not upregulate expression of the
chwann cell marker Oct-6 (Fig. 4J). Hence, the expression
f transcription factors that characterize distinct glial sub-
ypes is differentially regulated by extracellular signals:
ndogenous Erm protein expression is maintained by the
RG1 isoform GGF2 in satellite glia without induction of
ct-6 expression. In contrast, treatment with serum/
orskolin abolishes Erm expression and upregulates the
FIG. 3. Erm protein is expressed in satellite glia and in neuronal
cells of E16 DRG. DRG isolated from rat E16 embryos were
dissociated and the cells were fixed 4 h after plating and double
labeled for Erm and GFAP (A, C, E), for Erm and NF160 (insets in
A, C, E), or for Oct-6 and GFAP (B, D, F). Immunostaining for Erm
(A) was visualized using a biotin/avidin-amplified horseradish
peroxidase (HRP) reaction and bright-field optics. Note that Erm is
expressed both in NF160-positive neurons (detected by Cy3 fluo-
rescence; inset in C) and in GFAP-positive glia that were detected
by FITC immunofluorescence. In contrast, Oct-6 (B) is not detect-
able in freshly isolated cells of the DRG. (E, F) Phase-contrast
views. Bars, 20 mm.chwann cell marker Oct-6.
s of reproduction in any form reserved.
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51Ets Factor Erm in Satellite Glia but Not Schwann CellsGeneration of Two Distinct Glial Subtypes
from Erm-Positive Progenitor Cells
in Neural Crest Cultures
The transition from GFAP-positive satellite glia to
GFAP-positive Schwann cells might reflect a general plas-
ticity of glial subtypes (Le Douarin et al., 1991) or might
point to a lineage relationship of Erm-positive cells and
Schwann cells. In particular, neural crest cells might pro-
duce Erm-positive progenitor cells that generate satellite
glia in the presence of GGF2 and Schwann cells in the
presence of unidentified factors. Previously, cells marked
by the low-affinity neurotrophin growth factor receptor
(p75) have been isolated from neural crest explants and
shown to be multipotent and to be instructed to a glial fate
by GGF2 (Hagedorn et al., 1999; Shah et al., 1994; Stemple
and Anderson, 1992). Our analysis of similar neural crest
cultures revealed that approximately 85% of the p75-
positive cells were also positive for Erm expression (Figs.
5A–5C), indicating that the early expression of Erm in
neural crest cultures is independent of exogenously added
GGF2. Thus, this culture system allowed us to investigate
whether undifferentiated Erm-positive progenitors are able
to give rise to both satellite glia and Schwann cells, inde-
pendent of previous association with a DRG environment.
We confirmed that addition of GGF2 to cultured neural
crest cells promoted gliogenesis in the absence of neurons
(Hagedorn et al., 1999; Shah et al., 1994) and found that the
lia displayed features of satellite cells, as defined by the
resence of Erm and GFAP immunoreactivity and the
bsence of Oct-6 staining (Figs. 5H–5L). In contrast, when
rm-positive neural crest cells were treated with serum and
orskolin, neurons and glia were generated (Sommer et al.,
995; Stemple and Anderson, 1992), and virtually all of the
lia were Oct-6 positive but devoid of Erm expression, i.e.,
isplaying features of Schwann cells (Figs. 5D–5G). Thus,
ultured neural crest cells can give rise to two distinct glial
ublineages, satellite and Schwann cells, and these Schwann
ells are generated from Erm-positive progenitors.
Erm-Negative Glia Derived from DRG, but Not
Developing Schwann Cells, Display Competence
to Induce Erm Expression in Response to GGF2
The aforementioned experiments show that Erm-positive
progenitor cells and Erm-positive satellite glia have the f
cultures, or upon serum/forskolin treatment display distinct morphologies
Copyright © 2000 by Academic Press. All rightotential to adopt a Schwann cell fate. This could reflect
equential steps in a common lineage in which presumptive
atellite cells—i.e., nonneuronal Erm-positive cells residing
n the developing DRG—serve as a source for Schwann
ells. Alternatively, the transition from satellite cells to
chwann cells could simply represent plasticity between
eripheral glial subtypes. In the latter case, early Schwann
ells would presumably also have the capacity to generate
rm-positive satellite glia. To test this hypothesis, we
xposed Schwann cell precursors and early Schwann cells
Jessen et al., 1994) isolated from rat E14, E16, and E18
ciatic nerves to the NRG1 isoform GGF2 and analyzed
rm expression in such cultures. In accordance with the in
itu hybridization analysis (Figs. 1 and 2) freshly isolated
eveloping Schwann cells did not exhibit Erm expression
data not shown). Importantly, Erm protein expression was
either induced in Schwann cell precursors nor induced in
arly Schwann cells even after prolonged incubation with
GF2 (Figs. 6A and 6D; shown are the data from E16 sciatic
erve cells).
A possible explanation for this result might be that GGF2
s only able to maintain Erm expression in glial cells but not
o induce it. To identify whether GGF2 is able to induce
rm expression in glial cells, we made use of the DRG
ulture system. As described above (Fig. 4), satellite cells
ose Erm expression in standard medium and were negative
or both Erm (Fig. 6B) and Oct-6 (data not shown) after 3
ays in culture. Upon treatment with GGF2 for an addi-
ional 3 days, however, Erm protein expression was rein-
uced to high levels in virtually all cells (Figs. 6C). In
rinciple, these data could be accounted for by differential
election of residual Erm-positive cells upon GGF2 treat-
ent of 3-day cultures rather than by induction of Erm
xpression in Erm-negative cells. Given that in 3-day cul-
ures most glial cells were Erm negative (Fig. 6B), such an
nexpected selective activity of GGF2 (Hagedorn et al.,
999; Shah et al., 1994) would have to be accompanied by
ubstantial cell death, which we did not observe (data not
hown). Hence, the NRG1 isoform GGF2 not only main-
ains Erm expression in satellite cells but can also reinduce
t. The differential response to NRG1 signaling of glia
solated from DRG compared to developing Schwann cells
repared from peripheral nerves indicates an intrinsic dif-
erence of these glial subtypes and is consistent with anFIG. 4. Differential regulation of Erm and Oct-6 in glial subtypes derived from DRG. Dissociated DRG were cultured for 6 days in standard
medium (no add) (B, E, H, L), supplemented with fetal bovine serum and forskolin (A, D, G, K), or in the presence of the NRG1 isoform GGF2
(C, F, J, M). Cultures were double immunolabeled for GFAP (D–F, K–M) and for Erm (A–C) or Oct-6 (G–J). Cells cultured in standard medium were
also double labeled for NF160 (inset in E) and Erm (inset in B). Erm staining was revealed by a biotin/avidin-amplified HRP reaction, Oct-6 and
NF160 by Cy3 fluorescence, and GFAP by FITC fluorescence. In serum/forskolin, the Schwann cell marker Oct-6 was strongly expressed (G),
while Erm expression (A) was not detectable in GFAP-positive glia (D). Under “no add” conditions, glial Erm expression is abolished while
occasional neurons still express Erm (arrows and inset in B). Oct-6 is not expressed under these conditions (H). Upon addition of GGF2, glial cells
express Erm protein at high levels (C), comparable to the Erm expression in satellite cells of freshly isolated DRG (see Fig. 3). In contrast, Oct-6
expression is barely detectable in the presence of exogenous GGF2 (J). Note that glial cells obtained in standard culture medium, in GGF2-treated. Bars: (F, M) 50 mm; (inset) 20 mm.
s of reproduction in any form reserved.
t
(days in the presence of serum/forskolin (D–G) or of GGF2 (H–L)
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Copyright © 2000 by Academic Press. All rightirreversible developmental step from presumptive satellite
cells to Schwann cells.
DISCUSSION
Identifying traits that distinguish between neural crest-
derived glial subtypes are prerequisites to study their devel-
opmental relationship. We have shown here that the Ets
domain transcription factor Erm is differentially expressed
and regulated in distinct subsets of peripheral glia (Fig. 7).
To our knowledge, Erm is the first marker shown to be
expressed in presumptive satellite glia of sensory ganglia at
early developmental stages but not in Schwann cells of the
peripheral nerves. Maintaining Erm expression in cultured
satellite cells requires the continuous presence of a positive
signal that can be provided by the NRG1 isoform GGF2.
GGF2 also promotes the generation of satellite cells from
Erm-positive precursor cells in neural crest cultures, but
does not induce the Schwann cell marker Oct-6. Serum and
forskolin cause cultured Erm-positive neural crest cells and
presumptive satellite glia to generate Oct-6-positive
Schwann cells, while a similar transition from developing
Schwann cells to satellite glia upon treatment with GGF2
was not observed. Because in vivo Erm-positive cells are
detected in developing peripheral ganglia but not in periph-
eral nerves, our combined data suggest that Schwann cells
are likely derived from ganglionic Erm-positive progenitors.
Regulation of the Ets Domain Transcription Factor
Erm by NRG1 Signaling
The response of presumptive satellite cells to the NRG1
isoform GGF2 is reflected by regulated expression of endog-
enous Erm. Signaling of NRG1 is transmitted by the recep-
tors ErbB3 and ErbB4 and their coreceptors EGFR/ErbB1 and
ErbB2 (Burden and Yarden, 1997; Gassmann and Lemke,
1997; Riese and Stern, 1998). All ErbB receptor combina-
tions activate the Ras/MAP-kinase signaling cascade (Ben-
Levy et al., 1994; Hynes and Stern, 1994; Kim et al., 1995;
Marte et al., 1995; Pinkas-Kramarski et al., 1996; Si et al.,
1996; Tansey et al., 1996). Members of the Ets domain
transcription factor family are candidates for playing a role
in NRG1 signaling since several vertebrate Ets domain
transcription factors are transactivated by Ras/MAP-kinase
which promotes gliogenesis. These cultures were fixed and double
labeled for either Erm (D, H) and GFAP (F, K) or Oct-6 (E, J) and
GFAP (G, L). Erm labeling was revealed by a horseradish peroxidase
reaction while GFAP was detected by a secondary antibody conju-
gated to FITC and Oct-6 by a fluorescent Cy3-coupled secondary
antibody. Note that glial cells present in serum/forskolin-treated
cultures were Erm2/Oct-61 while glial cells generated from GGF2-
reated cultures expressed Erm but not Oct-6. Bars: (C) 20 mm;FIG. 5. Generation of distinct glial subtypes from Erm-positive
progenitor cells in neural crest cultures. Neural crest cells were
allowed to emigrate from rat E10.5 neural tubes in culture and were
replated. In some culture dishes, cells were labeled after 3 h with
anti-p75 antibody visualized by Cy3 fluorescence (B) and subse-
quently fixed and stained for Erm expression (A). (C) Phase-contrast
image. In other culture dishes, neural crest cells were grown for 11G, L) 50 mm.
s of reproduction in any form reserved.
53Ets Factor Erm in Satellite Glia but Not Schwann Cellsactivity (de Launoit et al., 1997; Janknecht, 1996; Janknecht
et al., 1996; Karin, 1994; Marais et al., 1993; O’Hagan et al.,
1996; Wasylyk et al., 1993; Yang et al., 1996). The Ets
domain transcription factors Pea3 and Ets-2 can also be
transactivated by overexpression of ErbB2 in a heterologous
cell system (Galang et al., 1996; O’Hagan and Hassell, 1998)
and Pea3 was found to be upregulated concomitantly with
ErbB2 in breast tumors (Benz et al., 1997; Trimble et al.,
1993). Moreover, Ets factor-binding sites were shown to be
crucial for NRG1- as well as MAP-kinase-dependent regu-
lation of utrophin and acetylcholine receptor (AChR) d and
e subunit gene expression (Khurana et al., 1999; Sapru et al.,
1998; Schaeffer et al., 1998). The effect of NRG1 signaling
FIG. 6. The NRG1 isoform GGF2 induces Erm expression in DRG
isolated from E16 sciatic nerve and cultured for 6 days (d) in the p
(A) and GFAP (D). Note that the HRP immunoreaction did not rev
immunofluorescence). (B, C, E, F) Dissociated E16 DRG were incu
dishes were fixed thereafter, sister dishes were cultured for an add
and GFAP (E, F) revealed that in standard medium Erm expression
with GGF2. Bar, 20 mm.on AChR d and e transcription appears to be mediated via
Copyright © 2000 by Academic Press. All rightthe Ets domain transcription factor GABPa (Schaeffer et al.,
1998). The identity of cell-endogenous Ets factors which
mediate NRG1 signaling in neural development, however,
has not been elucidated. Our data demonstrating regulation
of Erm expression by NRG1 are consistent with the hypoth-
esis that the Ets domain transcription factor Erm might
mediate cellular responses to NRG1 signaling during devel-
opment of satellite glia. This is also supported by our
findings that Erm is concomitantly expressed with NRG1
at several different embryonic sites including the develop-
ing DRG (data not shown). Moreover, NRG1 signaling and
Erm may share common targets. In cultured mammary
tumor cells, NRG1 induces the expression of the cellular
ved glia but not in early Schwann cells. (A, D) Schwann cells were
ce of GGF2. Cultures were fixed and double labeled for both Erm
rm expression in GFAP-positive Schwann cells (visualized by Cy3
in standard medium (n.a., no add) for 3 days. While some culture
al 3 days in the presence of GGF2. Double labeling for Erm (B, C)
nregulated in DRG-derived glia, but is reinduced upon treatment-deri
resen
eal E
bated
ition
is dowadhesion protein ICAM-1 (Bacus et al., 1993) whose pro-
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54 Hagedorn et al.moter can be activated by Erm (de Launoit et al., 1998). We
would expect that a direct target of NRG1 signaling should
be induced in DRG-derived glia within a few hours after
addition of GGF2. Reinduction of Erm in DRG cultures,
however, was observed only after at least 1 day of treatment
with GGF2 (data not shown), suggesting that Erm might not
be an immediate early target of NRG1 signaling. Alterna-
tively, the inhibitory mechanisms that led to Erm down-
regulation in DRG cultures might counteract the Erm-
inducing activity of GGF2. Thus, the detailed molecular
processes relating NRG1 signaling to Erm expression re-
main to be determined.
It is not clear whether NRG1 signaling is associated with
FIG. 7. Model of lineage relationship between Erm-positive cells
nd Schwann cells. Erm-negative migrating neural crest cells locate
o the Anlage of peripheral ganglia and give rise to Erm-positive
rogenitor cells that are devoid of differentiation markers such as
FAP and NF. These progenitors generate Erm-positive neurons
nd satellite cells. Erm expression in neurons is constitutive while
t is regulated in satellite glia by NRG1/GGF2. The model predicts
hat Erm-positive progenitors can emigrate from peripheral ganglia
nd have the potential to generate Erm-negative Schwann cells in
eripheral nerves. This competence is maintained by GFAP-
ositive presumptive satellite glia. The factor(s) inducing Schwann
ell traits are not yet defined but are likely to cause an irreversible
rogression in glia development.Erm expression at all stages of neural crest development. In
Copyright © 2000 by Academic Press. All righteural crest cultures, initial Erm protein expression appears
o be independent of exogenously added NRG1. Cultured
eripheral neurons constitutively express Erm irrespective
f whether or not the medium contains NRG1. Moreover,
n situ analysis of homozygous embryos (E12) containing a
argeted mutation in the ErbB3 locus (Riethmacher et al.,
997) suggests that the disruption of NRG1 signaling in
ivo does not prevent the early expression of Erm in DRG
L. Hagedorn, C. Paratore, D. Riethmacher, C. Birchmeier,
. Suter, and L. Sommer, unpublished results). However,
edundancies of signaling pathways could also account for
his result.
Intrinsic Differences between Peripheral
Glial Subtypes
The differential response to GGF2 of DRG-derived glia
compared to developing Schwann cells isolated from sciatic
nerves at various developmental stages reveals intrinsic
differences between presumptive satellite glia and Schwann
cells. Apparently, these differences are established early in
development, since neither Schwann cell precursors (E14)
nor early Schwann cells (E16–E18) (Jessen et al., 1994) were
competent to induce Erm expression upon NRG1 treat-
ment. Likewise, backtransplantation experiments in avian
embryos indicated differences between glial cells isolated
from distinct peripheral ganglia (Le Douarin et al., 1991).
The molecular basis for this is unclear. Although ErbB
receptors are able to undergo ligand-induced combinatorial
interactions with potential functional implications
(Vartanian et al., 1997), all neural crest-derived glia are
thought to transduce NRG1 signaling via the receptor
combination ErbB2/ErbB3 (Grinspan et al., 1996; Levi et al.,
1995; Shah et al., 1994; Vartanian et al., 1997). Neverthe-
less, NRG1 signaling in developing Schwann cells and
satellite glia might recruit different signal transduction
molecules. As mentioned above, activated ErbB receptors
stimulate the Ras/MAP-kinase signaling cascade, but addi-
tional pathways appear also to be involved (Hynes and
Stern, 1994; Tansey et al., 1996).
Schwann Cells Generated from Erm-Positive
Progenitor Cells
Our study on Erm expression and regulation is consistent
with the hypothesis (Fig. 7) that peripheral neurons, satel-
lite glia, and Schwann cells might derive from a common
Erm-positive progenitor in which Erm expression is down-
regulated upon acquisition of a Schwann cell fate. Since in
vivo Erm expression first appears in developing peripheral
ganglia, this model predicts that Schwann cells are gener-
ated from ganglionic progenitor cells. The differential regu-
lation of Erm in glial subtypes raises the question whether
Erm might play a role in maintaining satellite cell proper-
ties in glia of peripheral ganglia. Moreover, downregulation
of Erm might be linked with competence of glial precursors
to activate Schwann cell traits. In view of the proposed
s of reproduction in any form reserved.
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55Ets Factor Erm in Satellite Glia but Not Schwann Cellslineage relationship, the activation of Schwann cell features
in Erm-positive cells might be regarded as a progressive step
in peripheral glial development. Accordingly, a transition
from Schwann cell precursors or early Schwann cells to
satellite cells would correspond to a dedifferentiation step,
which is unlikely to occur and was not observed in our
cultures.
Consistent with our model (Fig. 7), we have recently
isolated a multipotent P0/PMP22-positive progenitor cell
type from rat E14 DRG that expresses Erm but not yet the
differentiation markers GFAP and NF160 (Hagedorn et al.,
1999; and data not shown). In culture, these cells can give
rise to neurons, nonneural cells, and GFAP1 glia (Hagedorn
t al., 1999). Depending on the extracellular factors added to
he cultures, the glia generated from these progenitors were
ither satellite cells expressing Erm but not Oct-6 or
chwann cells expressing Oct-6 but not Erm (data not
hown). Our data that Erm-positive progenitor cells derived
rom neural crest cultures or from E14 DRG and GFAP1
satellite glia from E16 DRG display the competence to
become Schwann cells corroborate the previous findings
that demonstrated transitions of satellite cells to SMP-
positive or Krox20-positive Schwann cells (Cameron-Curry
et al., 1993; Murphy et al., 1996; reviewed by Le Douarin et
l., 1993). Moreover, the idea that Schwann cells can
evelop from DRG-derived nonneuronal cells has also been
upported by the phenotype of mutant animals in which
rbB22/2 presumptive glia appear to stall in the nerve roots
f DRG and, as an assumed consequence, Schwann cells in
eripheral nerves are not generated (Morris et al., 1999).
ased on the combined data we suggest that Erm-positive
resumptive satellite glia might be able to emigrate from
he forming ganglia and to contribute to the Schwann cell
ineage along peripheral nerves. Emigration might result in
he loss of a local signal that is provided by the ganglionic
nvironment and required to maintain Erm expression and
he satellite glia state. Likely, this signal is the NRG1
soform GGF2 that is produced by neurons (Marchionni et
l., 1993; Shah et al., 1994) and might act in a paracrine
anner to regulate Erm expression in neighboring satellite
ells. Our hypothesis predicts that in vivo the cells emigrat-
ng from the forming ganglia encounter axons which do not
et produce local NRG1 or express NRG1 isoforms not able
o maintain Erm expression. Alternatively, downregulation
f Erm in vivo might require a repressive signal present
long peripheral axons which is capable of overriding the
RG1 effect on Erm expression.
Our model does not exclude alternative cellular pathways
n Schwann cell development. Clonal analysis of avian
eural crest identified some founder cells which gave rise
xclusively to SMP-positive Schwann cells, independent of
he generation of SMP-negative satellite cells or neurons
Dupin et al., 1990). However, precursor cells restricted to
he Schwann cell lineage were rare in lineage-tracing stud-
es of single premigratory and migratory neural crest cells in
ivo (Bronner-Fraser and Fraser, 1989; Frank and Sanes,
991; Fraser and Bronner-Fraser, 1991). Whether Erm-
Copyright © 2000 by Academic Press. All rightmmunoreactive cells indeed give rise to Schwann cells in
ivo must be addressed in future fate mapping experiments
Zinyk et al., 1998).
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